VT News
Tomas Totland

Tomas Totland

Ask VT AI
View News Summary
  • Eli Lilly acquires gene-editing biotech Verve Therapeutics for $1.3 billion, expanding its pipeline in cardiovascular therapies.
  • NHS staff warn of risks from patients filming treatments for social media, raising concerns over privacy, quality of care, and staff anxiety.
  • Yum! Brands names Chris Turner as new CEO, focusing on digital initiatives and value menus.
20 hours
USA flag

United States Politics

Discover the latest news, candidates, 
and key topics of US politics

Latest News
Ask VT AI
View News Summary
  • Eli Lilly acquires gene-editing biotech Verve Therapeutics for $1.3 billion, expanding its pipeline in cardiovascular therapies.
  • NHS staff warn of risks from patients filming treatments for social media, raising concerns over privacy, quality of care, and staff anxiety.
  • Yum! Brands names Chris Turner as new CEO, focusing on digital initiatives and value menus.
20 hours
USA flag

United States Politics

Discover the latest news, candidates, 
and key topics of US politics

Most Reported By
News from Tomas Totland

Top Topics

Trending in U.S.

World

Sport